Drew Goldberg

Oncoceutics, Inc. is a clinical-stage oncological biopharmaceutical company focused on fighting multiple cancer types including recurrent glioblastoma multiforme, myeloma, acute leukemia, mantle cell lymphoma and breast cancer. Drew will be helping to plan a combination clinical trial between Oncoceutics and another major pharmaceutical company, working daily with the venture capital member of the team, and assisting the team in data collection for their phase I trial with ONC201. Additionally, Drew will provide support to two consulting physicians on filing case report forms to the FDA.